Przemyslaw K.
- Country
- Poland
- Department
- Centrum Medyczne Medens-Grupowa Praktyka Lekarska
Research Overview
- Phase 2 Randomized Double-Blind Placebo-Controlled Study of ELV001 Add-On Therapy in Patients With Active Rheumatoid Arthritis Inadequate to Methotrexate and TNF Inhibition
- A Multi-Center Study to Characterize the Long-Term Safety and Efficacy of BMS-986165 in Subjects with Systemic Lupus Erythematosus
- Evaluation of Anifrolumab Efficacy and Safety in Systemic Sclerosis: A Phase III, Randomized, Double-Blind, Placebo-Controlled Study
Data & Insights
Has run more than one trial at 6 of 107 partner sites.
Specializations
Systemic Lupus Erythematosus and autoimmune disease research
Przemyslaw Kotyla is involved in clinical research centered on systemic lupus erythematosus, with a clear therapeutic focus on disease control, symptom burden, and long-term treatment safety. This area also extends to broader autoimmune diseases and immune system diseases, reflecting interest in immune-mediated inflammation and targeted immunomodulation.
- Systemic lupus erythematosus
- Autoimmune diseases
- Immune system diseases
His research activity includes evaluation of therapies aimed at improving clinical response and maintaining tolerability in chronic autoimmune conditions.
Systemic sclerosis and connective tissue disease care
Another major therapeutic area is systemic sclerosis, including both limited cutaneous and diffuse cutaneous subsets. The clinical focus here involves treatment of skin and organ manifestations, functional impact, and patient-reported disease burden in a complex connective tissue disease.
- Systemic sclerosis
- Limited cutaneous subset
- Diffuse cutaneous subset
This area highlights involvement in therapies designed to address the multisystem nature of fibrosing autoimmune disease.
Interstitial lung disease associated with immune-mediated disorders
Przemyslaw Kotyla also works in the field of interstitial lung disease, particularly in the context of systemic and autoimmune conditions. The therapeutic emphasis is on preserving pulmonary function and managing inflammatory lung involvement linked to broader immune dysregulation.
- Interstitial lung disease (ILD)
- Pulmonary involvement
- Immune-mediated lung disease
This area connects respiratory complications with systemic autoimmune pathology and treatment response.
Glioblastoma multiforme and neuro-oncology
His clinical trial involvement includes glioblastoma multiforme, with interest in treatment strategies for newly diagnosed high-grade brain tumors. The research focus is on integrating immunotherapy with standard oncologic care in neuro-oncology.
- Glioblastoma multiforme
- Neuro-oncology
- Immunotherapy
This area reflects participation in therapeutic innovation for aggressive central nervous system malignancies.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.